                         SEQUENCE LISTING

<110>  The Board of Trustees of the University of Arkansas
       Nakagawa, Mayumi
       Chang, Byeong S.
 
<120>  HUMAN PAPILLOMA VIRUS THERAPEUTIC VACCINE

<130>  110.047WO1

<150>  61/890,306
<151>  2013-10-13

<160>  5     

<170>  PatentIn version 3.5

<210>  1
<211>  158
<212>  PRT
<213>  Human papillomavirus type 16

<400>  1

Met His Gln Lys Arg Thr Ala Met Phe Gln Asp Pro Gln Glu Arg Pro 
1               5                   10                  15      


Arg Lys Leu Pro Gln Leu Cys Thr Glu Leu Gln Thr Thr Ile His Asp 
            20                  25                  30          


Ile Ile Leu Glu Cys Val Tyr Cys Lys Gln Gln Leu Leu Arg Arg Glu 
        35                  40                  45              


Val Tyr Asp Phe Ala Phe Arg Asp Leu Cys Ile Val Tyr Arg Asp Gly 
    50                  55                  60                  


Asn Pro Tyr Ala Val Cys Asp Lys Cys Leu Lys Phe Tyr Ser Lys Ile 
65                  70                  75                  80  


Ser Glu Tyr Arg His Tyr Cys Tyr Ser Leu Tyr Gly Thr Thr Leu Glu 
                85                  90                  95      


Gln Gln Tyr Asn Lys Pro Leu Cys Asp Leu Leu Ile Arg Cys Ile Asn 
            100                 105                 110         


Cys Gln Lys Pro Leu Cys Pro Glu Glu Lys Gln Arg His Leu Asp Lys 
        115                 120                 125             


Lys Gln Arg Phe His Asn Ile Arg Gly Arg Trp Thr Gly Arg Cys Met 
    130                 135                 140                 


Ser Cys Cys Arg Ser Ser Arg Thr Arg Arg Glu Thr Gln Leu 
145                 150                 155             


<210>  2
<211>  45
<212>  PRT
<213>  Human papillomavirus type 16

<400>  2

Met His Gln Lys Arg Thr Ala Met Phe Gln Asp Pro Gln Glu Arg Pro 
1               5                   10                  15      


Arg Lys Leu Pro Gln Leu Cys Thr Glu Leu Gln Thr Thr Ile His Asp 
            20                  25                  30          


Ile Ile Leu Glu Cys Val Tyr Cys Lys Gln Gln Leu Leu 
        35                  40                  45  


<210>  3
<211>  35
<212>  PRT
<213>  Human papillomavirus type 16

<400>  3

Arg Arg Glu Val Tyr Asp Phe Ala Phe Arg Asp Leu Cys Ile Val Tyr 
1               5                   10                  15      


Arg Asp Gly Asn Pro Tyr Ala Val Cys Asp Lys Cys Leu Lys Phe Tyr 
            20                  25                  30          


Ser Lys Ile 
        35  


<210>  4
<211>  35
<212>  PRT
<213>  Human papillomavirus type 16

<400>  4

Ser Glu Tyr Arg His Tyr Cys Tyr Ser Leu Tyr Gly Thr Thr Leu Glu 
1               5                   10                  15      


Gln Gln Tyr Asn Lys Pro Leu Cys Asp Leu Leu Ile Arg Cys Ile Asn 
            20                  25                  30          


Cys Gln Lys 
        35  


<210>  5
<211>  43
<212>  PRT
<213>  Human papillomavirus type 16

<400>  5

Pro Leu Cys Pro Glu Glu Lys Gln Arg His Leu Asp Lys Lys Gln Arg 
1               5                   10                  15      


Phe His Asn Ile Arg Gly Arg Trp Thr Gly Arg Cys Met Ser Cys Cys 
            20                  25                  30          


Arg Ser Ser Arg Thr Arg Arg Glu Thr Gln Leu 
        35                  40              


